Trial Tuesday: Same Trial, Two Verdicts, As Deramiocel Meets The FDA Panel
Manas Mishra
3 min read
members
Archive
Page 1 of 5
Milestone Monday: The Biotech Clocks Running Into 2027
Capsul Desk
5 min read
members
The Long View: A Generic You Forgot About Can Derail Your Trial
Capsul Desk
6 min read
members
Therapeutic Thursday: A Fringe RNA Drug Is Now First Of Its Kind In The Clinic
Capsul Desk
4 min read
members
Watchdog Wednesday: Is FDA’s Manufacturing Guidance A Trojan Horse?
Nielsen Hobbs
5 min read
members
Trial Tuesday: Another Chronic Cough Program Bites The Dust
Manas Mishra
3 min read
members
Milestone Monday: Thirteen Biotech IPOs In 2026, And Five More Just Got In Line
Capsul Desk
4 min read
members
The Long View: Pharma Is Paying More For Less-Proven Science
Capsul Desk
5 min read
members
Therapeutic Thursday: A Fine You Can Budget For
Capsul Desk
4 min read
members
Watchdog Wednesday: The Last CRL Before the Lights Went Out
Nielsen Hobbs
4 min read
members
Trial Tuesday: In Bleeding Disorders, The New Battleground Is The Calendar
Capsul Desk
5 min read
members
Milestone Monday: Pharma's Midyear Scorecard Starts Landing This Week
Capsul Desk
3 min read
members